The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
Codex DNA, which makes an automated synthetic biology workstation and related solutions, raised $107 million by offering 6.7 million shares at $16, the high end of the range of $14 to $16. Codex DNA states that its synthetic biology solution addresses the...read more
Codex DNA, which makes an automated synthetic biology workstation and related solutions, announced terms for its IPO on Monday.
The San Diego, CA-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. At the...read more
Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise...read more
US IPO Weekly Recap: IPO market in full swing as biotechs lead a 16 IPO week
The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
Synthetic biology solutions provider Codex DNA prices IPO at $16 high end
Codex DNA, which makes an automated synthetic biology workstation and related solutions, raised $107 million by offering 6.7 million shares at $16, the high end of the range of $14 to $16. Codex DNA states that its synthetic biology solution addresses the...read more
Synthetic biology solutions provider Codex DNA sets terms for $100 million IPO
Codex DNA, which makes an automated synthetic biology workstation and related solutions, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. At the...read more
US IPO Week Ahead: Biotechs and software lead a 15 IPO week
Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise...read more